WA
PRTK

WealthTrust-Arizona’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

WealthTrust-Arizona’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-100
Closed -$2K – 685
2017
Q1 		$2K Hold
100
– – ﹤0.01% 564
2016
Q4 		$2K Hold
100
– – ﹤0.01% 561
2016
Q3 		$1K Hold
100
– – ﹤0.01% 594
2016
Q2 		$1K Buy
+100
New +$1.47K ﹤0.01% 577

Other funds holding PRTK

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

WealthTrust-Arizona's PRTK Position: Q2 2017 in Review

WealthTrust-Arizona sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2017, closing a stake of 100 shares — an estimated $2K sold.

WealthTrust-Arizona first reported a position in PRTK in Q2 2016 and held it in 4 quarters. The position peaked at $2K in Q1 2017. 119 funds tracked by Wall St. Rank hold PRTK as of Q2 2017.

  • WealthTrust-Arizona reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
  • WealthTrust-Arizona sold 100 Paratek Pharmaceuticals, Inc. shares in Q2 2017, an estimated $2K.
  • WealthTrust-Arizona first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2016 and held it in 4 quarters.
  • WealthTrust-Arizona's Paratek Pharmaceuticals, Inc. position peaked at $2K in Q1 2017.
  • 119 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2017.

Based on WealthTrust-Arizona's 13F filing for Q2 2017, filed 21 Jul 2017.